Acute cellular rejection is the most common type and the most treatable — pulse IV methylprednisolone reverses it in most cases. Hyperacute rejection is prevented by pre-transplant crossmatch; it is irreversible. Chronic allograft nephropathy is the leading cause of late graft loss.